S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Is New IPO Instacart Already Hitting Speed Bumps?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Is New IPO Instacart Already Hitting Speed Bumps?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Is New IPO Instacart Already Hitting Speed Bumps?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Is NVIDIA Leading a "Magnificent Seven Bubble"? (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Is New IPO Instacart Already Hitting Speed Bumps?
BREAKING: Tiny biotech successfully treats blindness (Ad)
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
NASDAQ:ABIO

ARCA biopharma (ABIO) Stock Forecast, Price & News

$2.01
-0.05 (-2.43%)
(As of 09/22/2023 ET)
Compare
Today's Range
$2.01
▼
$2.06
50-Day Range
$2.00
▼
$2.07
52-Week Range
$1.85
▼
$2.70
Volume
10,910 shs
Average Volume
23,740 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

ABIO stock logo

About ARCA biopharma (NASDAQ:ABIO) Stock

ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.

ABIO Price History

ABIO Stock News Headlines

September 21, 2023 | msn.com
ARCA Wunderkind: NASCAR Fans Should 'Love' Who's Coming Down the Road
September 19, 2023 | americanbankingnews.com
ARCA biopharma, Inc. (NASDAQ:ABIO) Short Interest Down 7.0% in August
September 23, 2023 | Chaikin Analytics (Ad)
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
September 17, 2023 | americanbankingnews.com
ARCA biopharma (NASDAQ:ABIO) Coverage Initiated by Analysts at StockNews.com
September 10, 2023 | uk.finance.yahoo.com
ABIO - ARCA biopharma, Inc.
September 8, 2023 | msn.com
Rookie Connor Mosack wins first career ARCA race at Kansas Speedway
September 6, 2023 | msn.com
Five drivers to watch in Friday’s ARCA Sioux Chief Fast Track 150 at Kansas Speedway
August 22, 2023 | msn.com
Racing for Stride ARCA driver honors disabled veterans
September 23, 2023 | Chaikin Analytics (Ad)
"This Could be the Biggest Stock Story of 2023"
A.I. is set to create $7 trillion in new wealth but most investors are buying the wrong stocks. Learn what Wall Street insiders are buying here.
August 18, 2023 | msn.com
Watkins Glen Day 1 Recap: ARCA race comes down to final turn; tough day for Frankie Muniz
August 18, 2023 | msn.com
Love bumps Zilisch on last lap to win ARCA race at Watkins Glen
August 18, 2023 | msn.com
Frankie Muniz sees Watkins Glen as chance to earn first career ARCA victory
August 14, 2023 | msn.com
Corey LaJoie enters ARCA Menards Series race for Watkins Glen weekend
August 13, 2023 | msn.com
ARCA drivers Christian Rose, Conner Jones get into heated scuffle after spin out
August 11, 2023 | yahoo.com
Actor Turned Racer Frankie Muniz Is No Joke in ARCA Racing Series
July 30, 2023 | finanznachrichten.de
ARCA biopharma, Inc.: ARCA biopharma Announces Second Quarter 2023 Financial Results
July 27, 2023 | sports.yahoo.com
Sekisui Voltek Announces Sponsorship of Coldwater's Rodgers for ARCA race
July 21, 2023 | sports.yahoo.com
POCONOTES: Actor Muniz in middle of ARCA points battle
July 21, 2023 | finance.yahoo.com
ARCA biopharma Announces Second Quarter 2023 Financial Results
July 15, 2023 | msn.com
Fenhaus wins Calypso 150 in ARCA Menards Series
July 15, 2023 | sports.yahoo.com
'The end goal is the Cup Series': Frankie Muniz seeking more in NASCAR than hot ARCA start
July 13, 2023 | finance.yahoo.com
We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate
July 11, 2023 | msn.com
ARCA driver Sean Hingorani suspended for wrecking teammate
July 10, 2023 | yahoo.com
ARCA-Level NASCAR Driver Suspended for Wrecking Teammate
June 25, 2023 | msn.com
Frankie Muniz crashes hard in ARCA race, picks up first DNF
June 15, 2023 | msn.com
Frankie Muniz, Jesse Love and Christian Rose highlight who to watch for in the Berlin ARCA 200 this Saturday
May 4, 2023 | msn.com
Connor Mosack: "We’ve done everything in ARCA but win"
See More Headlines
Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Company Calendar

Last Earnings
7/21/2023
Today
9/22/2023
Next Earnings (Estimated)
10/27/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABIO
CUSIP
N/A
CIK
907654
Web
arcabio.com
Phone
(720) 940-2100
Fax
720-208-9261
Employees
5
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,930,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-15.43%
Return on Assets
-14.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
25.44
Quick Ratio
25.44

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
0.70

Miscellaneous

Outstanding Shares
14,410,000
Free Float
N/A
Market Cap
$28.96 million
Optionable
Not Optionable
Beta
1.30
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Michael R. Bristow M.D. (Age 78)
    Ph.D., Co-Founder, Pres, CEO & Director
    Comp: $358.8k
  • Mr. Thomas A. Keuer (Age 64)
    Chief Operating Officer
    Comp: $360.59k
  • Mr. C. Jeffrey Dekker CPA (Age 58)
    Chief Financial Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













ABIO Stock - Frequently Asked Questions

How have ABIO shares performed in 2023?

ARCA biopharma's stock was trading at $2.37 on January 1st, 2023. Since then, ABIO stock has decreased by 15.2% and is now trading at $2.01.
View the best growth stocks for 2023 here.

Are investors shorting ARCA biopharma?

ARCA biopharma saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 242,000 shares, a decline of 7.0% from the August 15th total of 260,300 shares. Based on an average trading volume of 23,000 shares, the short-interest ratio is presently 10.5 days. Approximately 1.7% of the company's stock are short sold.
View ARCA biopharma's Short Interest.

When is ARCA biopharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, October 27th 2023.
View our ABIO earnings forecast.

How were ARCA biopharma's earnings last quarter?

ARCA biopharma, Inc. (NASDAQ:ABIO) announced its earnings results on Friday, July, 21st. The biopharmaceutical company reported ($0.10) EPS for the quarter.

What is Michael R. Bristow's approval rating as ARCA biopharma's CEO?

1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ARCA biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP).

What is ARCA biopharma's stock symbol?

ARCA biopharma trades on the NASDAQ under the ticker symbol "ABIO."

Who are ARCA biopharma's major shareholders?

ARCA biopharma's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Western Standard LLC (0.00%) and BlackRock Inc. (0.00%). Insiders that own company stock include Christopher David Ozeroff, Fund Lp Funicular and Robert E Conway.
View institutional ownership trends.

How do I buy shares of ARCA biopharma?

Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ARCA biopharma's stock price today?

One share of ABIO stock can currently be purchased for approximately $2.01.

How much money does ARCA biopharma make?

ARCA biopharma (NASDAQ:ABIO) has a market capitalization of $28.96 million. The biopharmaceutical company earns $-9,930,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis.

How can I contact ARCA biopharma?

ARCA biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The official website for the company is arcabio.com. The biopharmaceutical company can be reached via phone at (720) 940-2100, via email at derek.cole@arcabio.com, or via fax at 720-208-9261.

This page (NASDAQ:ABIO) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -